Profile - To The Moon

mjvelonza

Posts · 201Posts · 201
Following · 0Following · 0
Followers · 0Followers · 0

- mjvelonzamjvelonza
  ·2022-01-06
  $Apple(AAPL)$Phew, got out just in time
  622 Comment
  3
  Share
  Report
- mjvelonzamjvelonza
  ·2021-09-22
  Why apple why
  459 Comment
  3
  Share
  Report
- mjvelonzamjvelonza
  ·2021-09-21
  Still a good time to buy the dip before recovery
  250 Comment
  2
  Share
  Report
- mjvelonzamjvelonza
  ·2021-09-21
  $NVIDIA Corp(NVDA)$Keeping steady in a sea of red
  481 1
  2
  Share
  Report
- mjvelonzamjvelonza
  ·2021-09-19
  The week of volatility ends last week. Looking at positive gains this coming week.
  231 Comment
  1
  Share
  Report
- mjvelonzamjvelonza
  ·2021-09-17
  Okay but why so poorly reflected in stock price?
  NRX Pharmaceuticals Treatment Trial Shows Significant Relief From Respiratory Distress In Critical COVID-19
  NRX Pharmaceuticals Inc :Nrx Pharmaceuticals Announces New Finding From Zyesami™ (Aviptadil) Phase 2
  NRX Pharmaceuticals Treatment Trial Shows Significant Relief From Respiratory Distress In Critical COVID-19
  140 Comment
  3
  Share
  Report
- mjvelonzamjvelonza
  ·2021-09-17
  $Tiger Brokers(TIGR)$Lol ggwp
  443 1
  5
  Share
  Report
- mjvelonzamjvelonza
  ·2021-09-17
  Recoveryyyy
  280 Comment
  1
  Share
  Report
- mjvelonzamjvelonza
  ·2021-09-15
  $NVIDIA Corp(NVDA)$Doing my happy dance
  363 1
  4
  Share
  Report
- mjvelonzamjvelonza
  ·2021-09-15
  Going to bounce back up to 20s resistance
  374 Comment
  2
  Share
  Report
No followers yet

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"4087426878489470","uuid":"4087426878489470","gmtCreate":1624324050037,"gmtModify":1624441110651,"name":"mjvelonza","pinyin":"mjvelonza","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/c5b17614ead945ff21352a4d3bbcd990","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":80,"headSize":262,"tweetSize":201,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.18","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.79%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":9008509957,"gmtCreate":1641476377119,"gmtModify":1676533618868,"author":{"id":"4087426878489470","authorId":"4087426878489470","name":"mjvelonza","avatar":"https://static.tigerbbs.com/c5b17614ead945ff21352a4d3bbcd990","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087426878489470","authorIdStr":"4087426878489470"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>Phew, got out just in time","listText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>Phew, got out just in time","text":"$Apple(AAPL)$Phew, got out just in time","images":[{"img":"https://static.itradeup.com/news/ea7ccb0e325db9e20927bcb07d8323f4","width":"1125","height":"3405"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9008509957","isVote":1,"tweetType":1,"viewCount":622,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":869195231,"gmtCreate":1632265576923,"gmtModify":1676530736390,"author":{"id":"4087426878489470","authorId":"4087426878489470","name":"mjvelonza","avatar":"https://static.tigerbbs.com/c5b17614ead945ff21352a4d3bbcd990","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087426878489470","authorIdStr":"4087426878489470"},"themes":[],"htmlText":"Why apple why","listText":"Why apple why","text":"Why apple why","images":[{"img":"https://static.tigerbbs.com/4114d4a6463246576d2091855c408ca8","width":"1125","height":"2875"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/869195231","isVote":1,"tweetType":1,"viewCount":459,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":869980372,"gmtCreate":1632234874396,"gmtModify":1676530731440,"author":{"id":"4087426878489470","authorId":"4087426878489470","name":"mjvelonza","avatar":"https://static.tigerbbs.com/c5b17614ead945ff21352a4d3bbcd990","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087426878489470","authorIdStr":"4087426878489470"},"themes":[],"htmlText":"Still a good time to buy the dip before recovery","listText":"Still a good time to buy the dip before recovery","text":"Still a good time to buy the dip before recovery","images":[{"img":"https://static.tigerbbs.com/c3f145fdf8a0e46e99f5c1338e5cc4fb","width":"1125","height":"2697"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/869980372","isVote":1,"tweetType":1,"viewCount":250,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":869917949,"gmtCreate":1632234843381,"gmtModify":1676530731415,"author":{"id":"4087426878489470","authorId":"4087426878489470","name":"mjvelonza","avatar":"https://static.tigerbbs.com/c5b17614ead945ff21352a4d3bbcd990","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087426878489470","authorIdStr":"4087426878489470"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NVDA\">$NVIDIA Corp(NVDA)$</a>Keeping steady in a sea of red","listText":"<a href=\"https://laohu8.com/S/NVDA\">$NVIDIA Corp(NVDA)$</a>Keeping steady in a sea of red","text":"$NVIDIA Corp(NVDA)$Keeping steady in a sea of red","images":[{"img":"https://static.tigerbbs.com/01b61acbc74cda37fc5bc8d834e6ebe0","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/869917949","isVote":1,"tweetType":1,"viewCount":481,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":887157922,"gmtCreate":1632011448266,"gmtModify":1676530685149,"author":{"id":"4087426878489470","authorId":"4087426878489470","name":"mjvelonza","avatar":"https://static.tigerbbs.com/c5b17614ead945ff21352a4d3bbcd990","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087426878489470","authorIdStr":"4087426878489470"},"themes":[],"htmlText":"The week of volatility ends last week. Looking at positive gains this coming week.","listText":"The week of volatility ends last week. Looking at positive gains this coming week.","text":"The week of volatility ends last week. Looking at positive gains this coming week.","images":[{"img":"https://static.tigerbbs.com/d4ea02c45c816c6970eac49886afcceb","width":"1125","height":"2711"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/887157922","isVote":1,"tweetType":1,"viewCount":231,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":884951645,"gmtCreate":1631849313787,"gmtModify":1676530652191,"author":{"id":"4087426878489470","authorId":"4087426878489470","name":"mjvelonza","avatar":"https://static.tigerbbs.com/c5b17614ead945ff21352a4d3bbcd990","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087426878489470","authorIdStr":"4087426878489470"},"themes":[],"htmlText":"Okay but why so poorly reflected in stock price?","listText":"Okay but why so poorly reflected in stock price?","text":"Okay but why so poorly reflected in stock price?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/884951645","repostId":"2163886644","repostType":2,"repost":{"id":"2163886644","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1630325942,"share":"https://ttm.financial/m/news/2163886644?lang=&edition=fundamental","pubTime":"2021-08-30 20:19","market":"hk","language":"en","title":"NRX Pharmaceuticals Treatment Trial Shows Significant Relief From Respiratory Distress In Critical COVID-19","url":"https://stock-news.laohu8.com/highlight/detail?id=2163886644","media":"T-Reuters","summary":"NRX Pharmaceuticals Inc :Nrx Pharmaceuticals Announces New Finding From Zyesami™ (Aviptadil) Phase 2","content":"<html><body><p>NRX Pharmaceuticals Inc <nrxp.o>:Nrx Pharmaceuticals Announces New Finding From Zyesami™ (Aviptadil) Phase 2B/3 Clinical Trial.Nrx Pharmaceuticals Inc -Zyesami Phase 2B/3 Clinical Trial Demonstrating Clinically Significant Relief From Respiratory Distress In Critical Covid-19.Nrx Pharmaceuticals Inc - Has Provided Updated Data To Us Fda In Support Of Emergency Use Authorization Request For Zyesami.Nrx Pharmaceuticals Inc -To Submit Breakthrough Therapy Designation To Fda For Zyesami For Treating Respiratory Failure In Critical Covid-19 Patients.Nrx Pharmaceuticals Inc -Patients Treated With Zyesami Showed  Improvement In Blood Oxygen, Within A Day Of Starting Treatment.</nrxp.o></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NRX Pharmaceuticals Treatment Trial Shows Significant Relief From Respiratory Distress In Critical COVID-19</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNRX Pharmaceuticals Treatment Trial Shows Significant Relief From Respiratory Distress In Critical COVID-19\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-08-30 20:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>NRX Pharmaceuticals Inc <nrxp.o>:Nrx Pharmaceuticals Announces New Finding From Zyesami™ (Aviptadil) Phase 2B/3 Clinical Trial.Nrx Pharmaceuticals Inc -Zyesami Phase 2B/3 Clinical Trial Demonstrating Clinically Significant Relief From Respiratory Distress In Critical Covid-19.Nrx Pharmaceuticals Inc - Has Provided Updated Data To Us Fda In Support Of Emergency Use Authorization Request For Zyesami.Nrx Pharmaceuticals Inc -To Submit Breakthrough Therapy Designation To Fda For Zyesami For Treating Respiratory Failure In Critical Covid-19 Patients.Nrx Pharmaceuticals Inc -Patients Treated With Zyesami Showed  Improvement In Blood Oxygen, Within A Day Of Starting Treatment.</nrxp.o></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"APR":"Apria, Inc.","CGEM":"Cullinan Therapeutics","LHDX":"Lucira Health, Inc.","NRXP":"NRX Pharmaceuticals Inc.","SANA":"Sana Biotechnology, Inc.","LABP":"Landos Biopharma, Inc."},"source_url":"https://www.trkd.thomsonreuters.com","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2163886644","content_text":"NRX Pharmaceuticals Inc :Nrx Pharmaceuticals Announces New Finding From Zyesami™ (Aviptadil) Phase 2B/3 Clinical Trial.Nrx Pharmaceuticals Inc -Zyesami Phase 2B/3 Clinical Trial Demonstrating Clinically Significant Relief From Respiratory Distress In Critical Covid-19.Nrx Pharmaceuticals Inc - Has Provided Updated Data To Us Fda In Support Of Emergency Use Authorization Request For Zyesami.Nrx Pharmaceuticals Inc -To Submit Breakthrough Therapy Designation To Fda For Zyesami For Treating Respiratory Failure In Critical Covid-19 Patients.Nrx Pharmaceuticals Inc -Patients Treated With Zyesami Showed  Improvement In Blood Oxygen, Within A Day Of Starting Treatment.","news_type":1},"isVote":1,"tweetType":1,"viewCount":140,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":884959257,"gmtCreate":1631849155779,"gmtModify":1676530652152,"author":{"id":"4087426878489470","authorId":"4087426878489470","name":"mjvelonza","avatar":"https://static.tigerbbs.com/c5b17614ead945ff21352a4d3bbcd990","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087426878489470","authorIdStr":"4087426878489470"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Lol ggwp","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Lol ggwp","text":"$Tiger Brokers(TIGR)$Lol ggwp","images":[{"img":"https://static.tigerbbs.com/1eebb6949f3583c48aace33daed23732","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/884959257","isVote":1,"tweetType":1,"viewCount":443,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":884950738,"gmtCreate":1631849106424,"gmtModify":1676530652136,"author":{"id":"4087426878489470","authorId":"4087426878489470","name":"mjvelonza","avatar":"https://static.tigerbbs.com/c5b17614ead945ff21352a4d3bbcd990","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087426878489470","authorIdStr":"4087426878489470"},"themes":[],"htmlText":"Recoveryyyy","listText":"Recoveryyyy","text":"Recoveryyyy","images":[{"img":"https://static.tigerbbs.com/cc550d87f8fbd827b1aaf4d6bf6e6cbe","width":"1125","height":"2711"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/884950738","isVote":1,"tweetType":1,"viewCount":280,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":882330669,"gmtCreate":1631660806551,"gmtModify":1676530600374,"author":{"id":"4087426878489470","authorId":"4087426878489470","name":"mjvelonza","avatar":"https://static.tigerbbs.com/c5b17614ead945ff21352a4d3bbcd990","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087426878489470","authorIdStr":"4087426878489470"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NVDA\">$NVIDIA Corp(NVDA)$</a>Doing my happy dance","listText":"<a href=\"https://laohu8.com/S/NVDA\">$NVIDIA Corp(NVDA)$</a>Doing my happy dance","text":"$NVIDIA Corp(NVDA)$Doing my happy dance","images":[{"img":"https://static.tigerbbs.com/961f749fd0870962c69a7e4f85bfd87e","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/882330669","isVote":1,"tweetType":1,"viewCount":363,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":882330010,"gmtCreate":1631660756930,"gmtModify":1676530600365,"author":{"id":"4087426878489470","authorId":"4087426878489470","name":"mjvelonza","avatar":"https://static.tigerbbs.com/c5b17614ead945ff21352a4d3bbcd990","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087426878489470","authorIdStr":"4087426878489470"},"themes":[],"htmlText":"Going to bounce back up to 20s resistance&nbsp;","listText":"Going to bounce back up to 20s resistance&nbsp;","text":"Going to bounce back up to 20s resistance","images":[{"img":"https://static.tigerbbs.com/980461aff5a4a5305635cf6687db0ffb","width":"1125","height":"2711"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/882330010","isVote":1,"tweetType":1,"viewCount":374,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"defaultTab":"followers","isTTM":true}